A challenge to the field of pharmacogenomics has been applying genetic tests meaningfully in the clinic. At The Corpus Callosum, a clinician blogs about the recent news that Neuromark has developed a genetic test to identify patients with increased susceptibility for suicide after starting taking an antidepressant.